Download
13058_2015_Article_521.pdf 445,51KB
WeightNameValue
1000 Titel
  • Coffee and tea consumption and risk of pre- and postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study
1000 Autor/in
  1. Bhoo-Pathy, Nirmala |
  2. Peeters, Petra HM |
  3. Uiterwaal, Cuno SPM |
  4. Bueno-de-Mesquita, H Bas |
  5. Bulgiba, Awang M |
  6. Bech, Bodil Hammer |
  7. Overvad, Kim |
  8. Tjønneland, Anne |
  9. Olsen, Anja |
  10. Clavel-Chapelon, Françoise |
  11. Fagherazzi, Guy |
  12. Perquier, Florence |
  13. Teucher, Birgit |
  14. Kaaks, Rudolf |
  15. Schütze, Madlen |
  16. Boeing, Heiner |
  17. Lagiou, Pagona |
  18. Orfanos, Philippos |
  19. Trichopoulou, Antonia |
  20. Agnoli, Claudia |
  21. Mattiello, Amalia |
  22. Palli, Domenico |
  23. Tumino, Rosario |
  24. Sacerdote, Carlotta |
  25. van Duijnhoven, Franzel JB |
  26. Braaten, Tonje |
  27. Lund, Eiliv |
  28. Skeie, Guri |
  29. Redondo, María-Luisa |
  30. Buckland, Genevieve |
  31. Pérez, Maria José Sánchez |
  32. Chirlaque, Maria-Dolores |
  33. Ardanaz, Eva |
  34. Amiano, Pilar |
  35. Wirfält, Elisabet |
  36. Wallström, Peter |
  37. Johansson, Ingegerd |
  38. Nilsson, Lena Maria |
  39. Khaw, Kay-Tee |
  40. Wareham, Nick |
  41. Allen, Naomi E |
  42. Key, Timothy J |
  43. Rinaldi, Sabina |
  44. Romieu, Isabelle |
  45. Gallo, Valentina |
  46. Riboli, Elio |
  47. van Gils, Carla H |
1000 Erscheinungsjahr 2015
1000 Art der Datei
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2015-01-31
1000 Erschienen in
1000 Quellenangabe
  • 17: 15
1000 FRL-Sammlung
1000 Copyrightjahr
  • 2015
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s13058-015-0521-3 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349221/ |
1000 Ergänzendes Material
  • https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-015-0521-3#Declarations |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • INTRODUCTION: Specific coffee subtypes and tea may impact risk of pre- and post-menopausal breast cancer differently. We investigated the association between coffee (total, caffeinated, decaffeinated) and tea intake and risk of breast cancer. METHODS: A total of 335,060 women participating in the European Prospective Investigation into Nutrition and Cancer (EPIC) Study, completed a dietary questionnaire from 1992 to 2000, and were followed-up until 2010 for incidence of breast cancer. Hazard ratios (HR) of breast cancer by country-specific, as well as cohort-wide categories of beverage intake were estimated. RESULTS: During an average follow-up of 11 years, 1064 premenopausal, and 9134 postmenopausal breast cancers were diagnosed. Caffeinated coffee intake was associated with lower risk of postmenopausal breast cancer: adjusted HR = 0.90, 95% confidence interval (CI): 0.82 to 0.98, for high versus low consumption; P trend = 0.029. While there was no significant effect modification by hormone receptor status (P = 0.711), linear trend for lower risk of breast cancer with increasing caffeinated coffee intake was clearest for estrogen and progesterone receptor negative (ER-PR-), postmenopausal breast cancer (P = 0.008). For every 100 ml increase in caffeinated coffee intake, the risk of ER-PR- breast cancer was lower by 4% (adjusted HR: 0.96, 95% CI: 0.93 to 1.00). Non-consumers of decaffeinated coffee had lower risk of postmenopausal breast cancer (adjusted HR = 0.89; 95% CI: 0.80 to 0.99) compared to low consumers, without evidence of dose–response relationship (P trend = 0.128). Exclusive decaffeinated coffee consumption was not related to postmenopausal breast cancer risk, compared to any decaffeinated-low caffeinated intake (adjusted HR = 0.97; 95% CI: 0.82 to 1.14), or to no intake of any coffee (HR: 0.96; 95%: 0.82 to 1.14). Caffeinated and decaffeinated coffee were not associated with premenopausal breast cancer. Tea intake was neither associated with pre- nor post-menopausal breast cancer. CONCLUSIONS: Higher caffeinated coffee intake may be associated with lower risk of postmenopausal breast cancer. Decaffeinated coffee intake does not seem to be associated with breast cancer.
1000 Fachgruppe
  1. Medizin |
  2. Gesundheitswesen |
  3. Ernährungswissenschaften |
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/creator/Qmhvby1QYXRoeSwgTmlybWFsYQ==|https://frl.publisso.de/adhoc/creator/UGVldGVycywgUGV0cmEgSE0=|https://frl.publisso.de/adhoc/creator/VWl0ZXJ3YWFsLCBDdW5vIFNQTQ==|https://frl.publisso.de/adhoc/creator/QnVlbm8tZGUtTWVzcXVpdGEsIEggQmFz|https://frl.publisso.de/adhoc/creator/QnVsZ2liYSwgQXdhbmcgTQ==|https://frl.publisso.de/adhoc/creator/QmVjaCwgQm9kaWwgSGFtbWVy|https://frl.publisso.de/adhoc/creator/T3ZlcnZhZCwgS2lt|https://frl.publisso.de/adhoc/creator/VGrDuG5uZWxhbmQsIEFubmU=|https://frl.publisso.de/adhoc/creator/T2xzZW4sIEFuamE=|https://frl.publisso.de/adhoc/creator/Q2xhdmVsLUNoYXBlbG9uLCBGcmFuw6dvaXNl|https://frl.publisso.de/adhoc/creator/RmFnaGVyYXp6aSwgR3V5|https://frl.publisso.de/adhoc/creator/UGVycXVpZXIsIEZsb3JlbmNl|https://frl.publisso.de/adhoc/creator/VGV1Y2hlciwgQmlyZ2l0|https://frl.publisso.de/adhoc/creator/S2Fha3MsIFJ1ZG9sZg==|https://frl.publisso.de/adhoc/creator/U2Now7x0emUsIE1hZGxlbg==|http://orcid.org/0000-0002-3358-1775|https://frl.publisso.de/adhoc/creator/TGFnaW91LCBQYWdvbmE=|https://frl.publisso.de/adhoc/creator/T3JmYW5vcywgUGhpbGlwcG9z|https://frl.publisso.de/adhoc/creator/VHJpY2hvcG91bG91LCBBbnRvbmlh|https://frl.publisso.de/adhoc/creator/QWdub2xpLCBDbGF1ZGlh|https://frl.publisso.de/adhoc/creator/TWF0dGllbGxvLCBBbWFsaWE=|https://frl.publisso.de/adhoc/creator/UGFsbGksIERvbWVuaWNv|https://frl.publisso.de/adhoc/creator/VHVtaW5vLCBSb3Nhcmlv|https://frl.publisso.de/adhoc/creator/U2FjZXJkb3RlLCBDYXJsb3R0YQ==|https://frl.publisso.de/adhoc/creator/dmFuIER1aWpuaG92ZW4sIEZyYW56ZWwgSkI=|https://frl.publisso.de/adhoc/creator/QnJhYXRlbiwgVG9uamU=|https://frl.publisso.de/adhoc/creator/THVuZCwgRWlsaXY=|https://frl.publisso.de/adhoc/creator/U2tlaWUsIEd1cmk=|https://frl.publisso.de/adhoc/creator/UmVkb25kbywgTWFyw61hLUx1aXNh|https://frl.publisso.de/adhoc/creator/QnVja2xhbmQsIEdlbmV2aWV2ZQ==|https://frl.publisso.de/adhoc/creator/UMOpcmV6LCBNYXJpYSBKb3PDqSBTw6FuY2hleg==|https://frl.publisso.de/adhoc/creator/Q2hpcmxhcXVlLCBNYXJpYS1Eb2xvcmVz|https://frl.publisso.de/adhoc/creator/QXJkYW5heiwgRXZh|https://frl.publisso.de/adhoc/creator/QW1pYW5vLCBQaWxhcg==|https://frl.publisso.de/adhoc/creator/V2lyZsOkbHQsIEVsaXNhYmV0|https://frl.publisso.de/adhoc/creator/V2FsbHN0csO2bSwgUGV0ZXI=|https://frl.publisso.de/adhoc/creator/Sm9oYW5zc29uLCBJbmdlZ2VyZA==|https://frl.publisso.de/adhoc/creator/Tmlsc3NvbiwgTGVuYSBNYXJpYQ==|https://frl.publisso.de/adhoc/creator/S2hhdywgS2F5LVRlZQ==|https://frl.publisso.de/adhoc/creator/V2FyZWhhbSwgTmljaw==|https://frl.publisso.de/adhoc/creator/QWxsZW4sIE5hb21pIEU=|https://frl.publisso.de/adhoc/creator/S2V5LCBUaW1vdGh5IEo=|https://frl.publisso.de/adhoc/creator/UmluYWxkaSwgU2FiaW5h|https://frl.publisso.de/adhoc/creator/Um9taWV1LCBJc2FiZWxsZQ==|https://frl.publisso.de/adhoc/creator/R2FsbG8sIFZhbGVudGluYQ==|https://frl.publisso.de/adhoc/creator/Umlib2xpLCBFbGlv|https://frl.publisso.de/adhoc/creator/dmFuIEdpbHMsIENhcmxhIEg=
1000 Label
1000 Förderer
  1. European Commission |
  2. International Agency for Research on Cancer |
  3. Danish Cancer Society |
  4. Ligue contre le Cancer, France |
  5. Mutuelle Générale de l’Education Nationale, France |
  6. Institut National de la Santé et de la Recherche Medicale, France |
  7. Deutsche Krebshilfe |
  8. Deutsches Krebsforschungszentrum |
  9. Federal Ministry of Education and Research, Germany |
  10. Hellenic Health Foundation, Greece |
  11. Italian Association for Research on Cancer (AIRC) |
  12. National Research Council, Italy |
  13. Dutch Ministry of Public Health, Welfare and Sports (VWS) |
  14. Netherlands Cancer Registry (NKR) |
  15. LK Research Funds, Netherlands |
  16. Dutch Prevention Funds, Netherlands |
  17. Dutch ZON (Zorg Onderzoek Nederland) |
  18. World Cancer Research Fund (WCRF), Netherlands |
  19. Statistics Netherlands |
  20. NordForsk, Norway |
  21. Health Research Fund (FIS), Spain |
  22. Regional Governments of Andalucía, Asturias, Basque Country, Murcia and Navarra, Spain |
  23. ISCIII RETIC, Spain |
  24. Swedish Cancer Society |
  25. Swedish Scientific Council |
  26. Regional Government of Skåne and Västerbotten, Sweden |
  27. Cancer Research UK |
  28. Medical Research Council, UK |
  29. European Union |
  30. Ministry of Higher Education, Malaysia |
1000 Fördernummer
  1. -
  2. -
  3. -
  4. -
  5. -
  6. -
  7. -
  8. -
  9. -
  10. -
  11. -
  12. -
  13. -
  14. -
  15. -
  16. -
  17. -
  18. -
  19. -
  20. 070015
  21. -
  22. -
  23. RD06/0020
  24. -
  25. -
  26. -
  27. -
  28. -
  29. MY/AsiaLink/044 (128–713)
  30. UM.C/HIR/MOHE/06
1000 Förderprogramm
  1. DG-SANCO
  2. -
  3. -
  4. -
  5. -
  6. -
  7. -
  8. -
  9. -
  10. -
  11. -
  12. -
  13. -
  14. -
  15. -
  16. -
  17. -
  18. -
  19. -
  20. Centre of Excellence programme HELGA
  21. -
  22. -
  23. -
  24. -
  25. -
  26. -
  27. -
  28. -
  29. AsiaLink program
  30. High Impact Research Grant
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer European Commission |
    1000 Förderprogramm DG-SANCO
    1000 Fördernummer -
  2. 1000 joinedFunding-child
    1000 Förderer International Agency for Research on Cancer |
    1000 Förderprogramm -
    1000 Fördernummer -
  3. 1000 joinedFunding-child
    1000 Förderer Danish Cancer Society |
    1000 Förderprogramm -
    1000 Fördernummer -
  4. 1000 joinedFunding-child
    1000 Förderer Ligue contre le Cancer, France |
    1000 Förderprogramm -
    1000 Fördernummer -
  5. 1000 joinedFunding-child
    1000 Förderer Mutuelle Générale de l’Education Nationale, France |
    1000 Förderprogramm -
    1000 Fördernummer -
  6. 1000 joinedFunding-child
    1000 Förderer Institut National de la Santé et de la Recherche Medicale, France |
    1000 Förderprogramm -
    1000 Fördernummer -
  7. 1000 joinedFunding-child
    1000 Förderer Deutsche Krebshilfe |
    1000 Förderprogramm -
    1000 Fördernummer -
  8. 1000 joinedFunding-child
    1000 Förderer Deutsches Krebsforschungszentrum |
    1000 Förderprogramm -
    1000 Fördernummer -
  9. 1000 joinedFunding-child
    1000 Förderer Federal Ministry of Education and Research, Germany |
    1000 Förderprogramm -
    1000 Fördernummer -
  10. 1000 joinedFunding-child
    1000 Förderer Hellenic Health Foundation, Greece |
    1000 Förderprogramm -
    1000 Fördernummer -
  11. 1000 joinedFunding-child
    1000 Förderer Italian Association for Research on Cancer (AIRC) |
    1000 Förderprogramm -
    1000 Fördernummer -
  12. 1000 joinedFunding-child
    1000 Förderer National Research Council, Italy |
    1000 Förderprogramm -
    1000 Fördernummer -
  13. 1000 joinedFunding-child
    1000 Förderer Dutch Ministry of Public Health, Welfare and Sports (VWS) |
    1000 Förderprogramm -
    1000 Fördernummer -
  14. 1000 joinedFunding-child
    1000 Förderer Netherlands Cancer Registry (NKR) |
    1000 Förderprogramm -
    1000 Fördernummer -
  15. 1000 joinedFunding-child
    1000 Förderer LK Research Funds, Netherlands |
    1000 Förderprogramm -
    1000 Fördernummer -
  16. 1000 joinedFunding-child
    1000 Förderer Dutch Prevention Funds, Netherlands |
    1000 Förderprogramm -
    1000 Fördernummer -
  17. 1000 joinedFunding-child
    1000 Förderer Dutch ZON (Zorg Onderzoek Nederland) |
    1000 Förderprogramm -
    1000 Fördernummer -
  18. 1000 joinedFunding-child
    1000 Förderer World Cancer Research Fund (WCRF), Netherlands |
    1000 Förderprogramm -
    1000 Fördernummer -
  19. 1000 joinedFunding-child
    1000 Förderer Statistics Netherlands |
    1000 Förderprogramm -
    1000 Fördernummer -
  20. 1000 joinedFunding-child
    1000 Förderer NordForsk, Norway |
    1000 Förderprogramm Centre of Excellence programme HELGA
    1000 Fördernummer 070015
  21. 1000 joinedFunding-child
    1000 Förderer Health Research Fund (FIS), Spain |
    1000 Förderprogramm -
    1000 Fördernummer -
  22. 1000 joinedFunding-child
    1000 Förderer Regional Governments of Andalucía, Asturias, Basque Country, Murcia and Navarra, Spain |
    1000 Förderprogramm -
    1000 Fördernummer -
  23. 1000 joinedFunding-child
    1000 Förderer ISCIII RETIC, Spain |
    1000 Förderprogramm -
    1000 Fördernummer RD06/0020
  24. 1000 joinedFunding-child
    1000 Förderer Swedish Cancer Society |
    1000 Förderprogramm -
    1000 Fördernummer -
  25. 1000 joinedFunding-child
    1000 Förderer Swedish Scientific Council |
    1000 Förderprogramm -
    1000 Fördernummer -
  26. 1000 joinedFunding-child
    1000 Förderer Regional Government of Skåne and Västerbotten, Sweden |
    1000 Förderprogramm -
    1000 Fördernummer -
  27. 1000 joinedFunding-child
    1000 Förderer Cancer Research UK |
    1000 Förderprogramm -
    1000 Fördernummer -
  28. 1000 joinedFunding-child
    1000 Förderer Medical Research Council, UK |
    1000 Förderprogramm -
    1000 Fördernummer -
  29. 1000 joinedFunding-child
    1000 Förderer European Union |
    1000 Förderprogramm AsiaLink program
    1000 Fördernummer MY/AsiaLink/044 (128–713)
  30. 1000 joinedFunding-child
    1000 Förderer Ministry of Higher Education, Malaysia |
    1000 Förderprogramm High Impact Research Grant
    1000 Fördernummer UM.C/HIR/MOHE/06
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6405729.rdf
1000 Erstellt am 2017-12-07T15:49:32.287+0100
1000 Erstellt von 218
1000 beschreibt frl:6405729
1000 Bearbeitet von 218
1000 Zuletzt bearbeitet Thu Jan 30 18:30:04 CET 2020
1000 Objekt bearb. Tue Sep 04 10:03:25 CEST 2018
1000 Vgl. frl:6405729
1000 Oai Id
  1. oai:frl.publisso.de:frl:6405729 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source